Select Publications
Conference Abstracts
2017, 'MDT V NON-MDT CARE IN LUNG CANCER: DOES CO-MORBIDITY STATUS HAVE AN IMPACT?', in RESPIROLOGY, WILEY, Vol. 22, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000396791000049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'PULMONARY GRAFT VERSUS HOST DISEASE ASSESSMENT OF LOCAL SCREENING AND DIAGNOSTIC PRACTICES', in RESPIROLOGY, WILEY, Vol. 22, pp. 167 - 167, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000396791000309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Dependence of fluorodeoxyglucose avidity on tumour size in non-small cell lung cancer', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SINGAPORE, Singapore, Vol. 26, pp. 153 - 154, presented at Asia Congress of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, Singapore, 18 December 2015 - 21 December 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367158700499&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'DEPENDENCE OF FLUORODEOXYGLUCOSE (FDG) AVIDITY ON TUMOUR SIZE IN NON-SMALL CELL LUNG CANCER (NSCLC)', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, Vol. 11, pp. 121 - 121, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'EBUS-TBNA LYMPH NODE NOMENCLATURE AND VARIATIONS ACROSS STAGING MODALITIES FOR NON-SMALL CELL LUNG CARCINOMA', in RESPIROLOGY, WILEY-BLACKWELL, AUSTRALIA, Queensland, Vol. 20, pp. 149 - 149, presented at Thoracic Society Australia New Zealand Australian New Zealand Society Respiratory Science Annual Scientific Meeting 2015, AUSTRALIA, Queensland, 27 March 2015 - 01 April 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351464400388&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'LUNG ADENOCARCINOMA BIOMARKER SCREENING IN AN AUSTR'ALIAN POPULATION', in JOURNAL OF THORACIC ONCOLOGY, ELSEVIER SCIENCE INC, AUSTRALIA, Adelaide, Vol. 7, pp. S158 - S158, presented at 4th Australian Lung Cancer Conference, AUSTRALIA, Adelaide, 23 August 2012 - 25 August 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000317034900003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'EBUS in primary lung cancer', in Journal of Thoracic Oncology, Elsevier, Vol. 6, pp. S1510 - S1510, presented at 14th World Conference on Lung Cancer
,Reports
2016, Ectopic Cushing syndrome due to neuroendocrine prostatic cancer, http://dx.doi.org/10.1111/imj.13063
,Preprints
2021, Care to Quit: A stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres, http://dx.doi.org/10.21203/rs.3.rs-127472/v2
,2020, Care to Quit: A Stepped Wedge Cluster Randomised Controlled Trial to Implement Best Practice Smoking Cessation Care in Cancer Centres, http://dx.doi.org/10.21203/rs.3.rs-127472/v1
,Other
2019, Indeed, Nuance Matters, http://dx.doi.org/10.1016/j.jtho.2018.11.004
,